Navigation Links
Medivation Reports Third Quarter 2010 Financial Results and Provides Corporate Update
Date:11/5/2010

in Huntington disease and the Phase 3 AFFIRM trial in advanced prostate cancer patients who have failed chemotherapy..

Conference Call InformationTo participate by telephone in today's live call beginning at 4:30 p.m. Eastern Time, please call 877-303-2523 from the U.S. or +1-253-237-1755 internationally.  In addition, the live conference call is being webcast and can be accessed on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at www.medivation.com.  A replay also will be available for 30 days following the live call.

About MedivationMedivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partners Pfizer and Astellas, Medivation currently has investigational drugs in Phase 3 development to treat advanced prostate cancer, mild-to-moderate Alzheimer's disease and Huntington disease. For more information, please visit us at www.medivation.com.

This press release contains forward-looking statements, including statements regarding the continued clinical development of Medivation's product candidates, the potential completion of patient enrollment in ongoing clinical trials, the potential initiation of new clinical trials and the potential conduct of an interim analysis in the AFFIRM study, the anticipated timing of announcement of top-line data from ongoing clinical trials and other statements with respect to future clinical trial results, the therapeutic and commercial potential of Medivation's product candidates, the continued effectiveness of, and continuing activities under, Medivation's collaboration agreements with
'/>"/>

SOURCE Medivation, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Medivation Announces Third Quarter 2010 Financial Results Teleconference and Webcast on November 5, 2010
2. Medivation Announces Second Quarter 2010 Financial Results Teleconference and Webcast on August 9, 2010
3. Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
4. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
5. Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
6. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
7. Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
8. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
9. Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
10. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
11. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015  Mytrus, a technology and services company revolutionizing ... electronic informed consent has received approval for use by ... It is the first time e-Consent technology will be ... . Mytrus was also the first ... clinical trial by the U.S. Food and Drug Administration ...
(Date:8/27/2015)... 27, 2015   Americord Registry , a private ... placenta tissue banking company, announced today the ... website. This new website makes the expecting parent,s cord ... shopping cart and checkout process. Logo - ... banking websites make this service difficult to purchase online. ...
(Date:8/27/2015)... 2015 According to a ... titled "Global Market Study on Urinary Catheters: Intermittent ... the urinary catheters market is expected to be valued at ... is anticipated to expand at a CAGR of4.1% ... by 2021. View full report TOC at: ...
Breaking Medicine Technology:Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 5Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 6Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 7Cord Blood Bank Revolutionizes Process of Online Cord Blood Banking 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 3Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 4
... BEDFORD, Ohio,  April 18, 2011 Bedford Laboratories™, ... pleased to announce the addition of Topotecan Hydrochloride ... portfolio.  Topotecan is AP Bioequivalent to the reference ... injection by GlaxoSmithKline. Topotecan Hydrochloride for Injection is ...
... April 18, 2011 Qmed.com, a UBM Canon ... informative video clips of products and services available ... Vault . Qmed is a free online search ... access to pre-qualified medical device suppliers. ...
Cached Medicine Technology:Bedford Laboratories™ to Begin Shipping Topotecan Hydrochloride for Injection, 4mg SD Vial 2Qmed Video Vault Showcases Innovative New Products and Services Available to Medical Device Manufacturers 2
(Date:8/27/2015)... Memphis,TN (PRWEB) , ... August 28, 2015 , ... ... hardships of youth aging out of foster care through “The Language of Flowers,” ... in supporting Youth Villages’ work, particularly the organization’s YVLifeSet program, was piqued by ...
(Date:8/27/2015)... ... 27, 2015 , ... Keck Graduate Institute (KGI), School of Pharmacy celebrated its ... a formal ceremony recognizing them as members of the 2nd class of the KGI ... Symbolizing dedication to clinical service and patient care, the White Coat Ceremony is held ...
(Date:8/27/2015)... , ... August 27, 2015 , ... In the addiction ... leaving weeks or months later, relapsing and returning again, all at great cost to ... while in sober living homes or soon after leaving facilities who claim to have ...
(Date:8/27/2015)... ... August 27, 2015 , ... According to an ... on Abdominal Wall Hernia Surgery involved many conversations between hernia experts surrounding the search ... the article notes that many different experts have different ideas about which is the ...
(Date:8/27/2015)... ... ... Thriveology Founders, Dr. Carly Letzt Carney and Dr. Mark Carney announced today that ... on Saturday, August 29, 2015 at the Marriott DTC, 4900 S. Syracuse Street, Denver, ... will present a two part seminar entitled, “How to Thrive as You Age & ...
Breaking Medicine News(10 mins):Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 3Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 2Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 3Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 4Health News:National Screenings of Documentary Indicate Burgeoning Questions about the Effectiveness of Addiction Treatment Facilities 2Health News:National Screenings of Documentary Indicate Burgeoning Questions about the Effectiveness of Addiction Treatment Facilities 3Health News:Recent Article on Hernia Mesh Developments Highlights Viable Options, But Shows a Need for Further Research, notes Dr. Shirin Towfigh 2Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2
... fossil teeth has thrown new light on the recent origin ... beings apart from their primate ancestors, according to an article ... of the fossil teeth, researchers from University College, London and ... 25 year development period of humans compared with 11 or ...
... Increasing folic acid intake and decreasing alcohol help beat the ... According to previous studies have shown that colon cancer often ... with the disease, you can opt for regular colon exams, ... and vegetables to reduce your cancer risk. ,According ...
... art is regnant among undergraduate university students, and there ... piercing,"// said Dr. Lester B. Mayers of the Pace ... lead author of the study. ,A survey ... had some type of body piercing and 22 percent ...
... ,According to researchers at the Hopkins Heart Institute, a blunt and ... When it comes to accidents and sports injuries,// it is a ... at the a blow to the chest may prove more hazardous. ... type of cardiac arrest called commotio cordis, which occurred after a ...
... dangerous parasitic disease from their new organs in the ... one recovered after antibiotic treatment.// A second study also ... turned up 26 bacterial infections traced to tissue grafts ... ,This shows that the graft-related infections show an ...
... prototype handheld detector under development at Sandia National Laboratories ... anthrax in less than five minutes. //Sandia's Laboratory Directed ... a multiprogram laboratory operated by Sandia Corporation, a Lockheed ... ,Fatty acids are found in all living organisms with ...
Cached Medicine News:
5mSports™ is the handheld version of 5 Minute Sports Medicine Consult, your favorite reference for on-field and off-field treatment of sports related problems....
... involved with healthcare decisions to keep up ... in their field of interest - a ... the volume of evidence increases. Cochrane Reviews ... single source available for continually updated evidence-based ...
... information that every intern needs from ... the neurologic history and physical examination, ... and diagnostic tools, and clinical information ... ataxia, acute vision loss, headache, movement ...
... an all-original guide prepared specifically ... Derived from "PocketMedicine/Internal Medicine", it ... to those training in the ... who are frequently the first ...
Medicine Products: